FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades – CNBC

FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades CNBC
F.D.A. Approves the First New Schizophrenia Drug in Decades The New York Times
FDA eyes first schizophrenia drug shift in decades Axios
Schizophrenia Space Anticipates First-in-Class FDA Approval for BMS’ KarXT BioSpace
FDA approves 1st new drug for schizophrenia in more than 30 years ABC News